- Home
- BNC vs BIOA Comparison
BNC vs BIOA Comparison
Compare BNC & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNC
- BIOA
- Stock Information
- Founded
- BNC N/A
- BIOA 2015
- Country
- BNC United States
- BIOA United States
- Employees
- BNC 164
- BIOA N/A
- Industry
- BNC Industrial Machinery/Components
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- BNC Industrials
- BIOA Health Care
- Exchange
- BNC Nasdaq
- BIOA Nasdaq
- Market Cap
- BNC 215.8M
- BIOA 175.7M
- IPO Year
- BNC N/A
- BIOA 2024
- Fundamental
- Price
- BNC $5.07
- BIOA $7.92
- Analyst Decision
- BNC
- BIOA Hold
- Analyst Count
- BNC 0
- BIOA 4
- Target Price
- BNC N/A
- BIOA $9.00
- AVG Volume (30 Days)
- BNC 661.2K
- BIOA 667.7K
- Earning Date
- BNC 12-23-2025
- BIOA 11-06-2025
- Dividend Yield
- BNC N/A
- BIOA N/A
- EPS Growth
- BNC N/A
- BIOA N/A
- EPS
- BNC N/A
- BIOA N/A
- Revenue
- BNC $4,027,431.00
- BIOA $5,917,000.00
- Revenue This Year
- BNC N/A
- BIOA N/A
- Revenue Next Year
- BNC N/A
- BIOA N/A
- P/E Ratio
- BNC N/A
- BIOA N/A
- Revenue Growth
- BNC 27.46
- BIOA N/A
- 52 Week Low
- BNC $4.84
- BIOA $2.88
- 52 Week High
- BNC $82.88
- BIOA $21.45
- Technical
- Relative Strength Index (RSI)
- BNC 27.81
- BIOA 63.60
- Support Level
- BNC $5.33
- BIOA $6.75
- Resistance Level
- BNC $6.28
- BIOA $8.14
- Average True Range (ATR)
- BNC 0.45
- BIOA 0.44
- MACD
- BNC 0.08
- BIOA -0.03
- Stochastic Oscillator
- BNC 6.12
- BIOA 72.86
About BNC CEA Industries Inc. Common Stock
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.